Clinical Trial Update: A Trial of Tisotumab Vedotin in Cervical Cancer [Phase 2]

View source ↗

Summary

Phase 2 clinical trial of tisotumab vedotin in cervical cancer has completed and results were posted in 2021.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cervical Cancer

Drugs mentioned

• Tisotumab Vedotin (tisotumab vedotin)

Snippet

Sponsor: Seagen Inc. | Conditions: Cervical Cancer | Phase 2 | Status: COMPLETED | Results posted: 2021-11-04